@FiercePharma: Top-read in FiercePharma Thurs: Eli Lilly continues downward spiral in Q3 as generics slam Cymbalta, Evista sales. Story | Follow @FiercePharma
@CarlyHFierce: ICYMI: This week's issue of FierceVaccines. To get it weekly, subscribe. Subscribe | Follow @CarlyHFierce
> Novo Nordisk ($NVO) reported today that it has been subpoenaed by the U.S. Attorney in Massachusetts over manufacturing issues at a plant in Denmark. Release
> The head of AbbVie's ($ABBV) Canada operations said the country is unlikely to get much R&D investment as long as its patents on drugs is more restrictive than other Western countries. Story
> Jordan's Hikma reports that it has gotten a warning letter from the FDA for a plant in Portugal. Story
Medical Device News
@FierceMedDev: New microscope offers 3D cellular images that are fast, detailed and low toxicity. More | Follow @FierceMedDev
@VarunSaxena2: Bard Q3 earnings up 41% as it focuses on Lutonix launch. Story | Follow @VarunSaxena2
@EmilyWFierce: $JNJ scores victory in first metal-on-metal hip implant case to go to trial. Article | Follow @EmilyWFierce
@MichaelGFierce: Encapsulated #Alzheimers, #Parkinsons-treating growth factors implanted directly in the brain. More from FierceDrugDelivery | Follow @MichaelGFierce
> Apple kicks med tech app developers out of the iCloud. Item
> Edwards profit up 23%, but increased TAVR competition looming. Story
Biotech News
@FierceBiotech: $GSK cozies up to Five Prime for respiratory R&D. More | Follow @FierceBiotech
@JohnCFierce: Baxter gets FDA OK for hemophilia A drug -- Obizur. News | Follow @JohnCFierce
@DamianFierce: $AZN's olaparib will trade as Lynparza, which sounds like a nice lady. | Follow @DamianFierce
@EmilyMFierce: Researchers will test blood of Ebola survivors to use as a short-term treatment option. Story | Follow @EmilyMFierce
> AstraZeneca gets some EU encouragement for its $2B cancer hopeful. More
> Shire CFO to exit in wake of failed AbbVie deal. Chutes & Ladders
> NPS Pharma will have to wait another three months for an FDA OK. News
And Finally... Your milk choice may impact your vitamin D levels. More (sub. req.)